Skip to main content
. Author manuscript; available in PMC: 2011 Apr 15.
Published in final edited form as: Cancer. 2010 Apr 15;116(8):1918–1925. doi: 10.1002/cncr.24997

Figure 2.

Figure 2

Kaplan-Meier estimates of the probability of survival in patients with high CFDNA levels (≥ 22,000 GE/ml, dotted line) vs. those with low CFDNA levels (< 22,000 GE/ml, full line) in Training Set (A). This cutoff was validated in a separate cohort of patients, Validation Set (B). Two-sided log rank test provided a significant p-value < 0.001.